Medifast Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Medifast Stock Forecast and Price Target
Given the average yearlong price target of $37.50 provided by two prominent analysts over the past few months, there is a potential upside of approximately 11.71% from the last closing price in April, 2024 for Medifast's stock if it is reached. This estimation is based on a high estimate of $40.00 and a low estimate of $35.00. If you are interested in MED stock, it is important to also consider its competitors.
11.71% Upside
Medifast Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Medifast's Price has seen a drop from $140.21 to $0.00 – a 100.00% decrease. Next year, analysts are expecting Fair Value to reach $117.81 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRBR Stock Forecast | BellRing Brands | Outperform |
16
|
$55.62 | Buy/Sell | $52.21 | 13.27% |
| SMPL Stock Forecast | Simply Good Foods Co-The | Outperform |
15
|
$34.34 | Buy/Sell | $40.58 | 19.39% |
| USNA Stock Forecast | USANA Health Sciences | Hold |
14
|
$43.70 | Buy/Sell | $104.00 | 29.29% |
| JWEL Stock Forecast | Jamieson Wellness | Outperform |
18
|
C$26.17 | Buy/Sell | C$38.40 | 35.65% |
| HLF Stock Forecast | Herbalife | Outperform |
16
|
$9.20 | Buy/Sell | $17.90 | 8.70% |
Medifast Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Medifast's Revenue has grown from $934.84M to $1.07B – a 14.68% increase. According to 2 major analysts, Medifast's Revenue will fall by 16.30% in the next year, reaching $897.35M. Professionals believe that By 2030, Medifast's Revenue will fall to $901.06M– a 15.95% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NUS Stock Forecast | Nu Skin Enterprises | Hold |
18
|
$12.47 | Buy/Sell | $21.00 | 12.27% |
| BYND Stock Forecast | Beyond Meat | Underperform |
5
|
$6.06 | Buy/Sell | $6.25 | -0.99% |
| NATR Stock Forecast | Nature's Sunshine Products | Buy |
16
|
$19.52 | Buy/Sell | $21.50 | 22.95% |
.jpg)
Medifast Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Medifast's Dividend per Share has grown by 9.51%, rising from $4.52 to $4.95. In the next year, 0 analysts estimate that Medifast's Dividend per Share will decrease by 0.43%, reaching $4.93. Over the next seven years, experts predict that Medifast's Dividend per Share will grow at a rate of 9.58%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WW Stock Forecast | WW International | Outperform |
16
|
$1.66 | Buy/Sell | $11.79 | 216.27% |
| LFVN Stock Forecast | LifeVantage |
0
|
$6.17 | Buy/Sell | $7.00 | -100.00% | |
| TUP Stock Forecast | Tupperware Brands | - |
18
|
$1.02 | Buy/Sell | $4.00 | -100.00% |
Medifast EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Medifast's EBITDA has decreased from $142.47M to $139.51M – a 2.08% drop. In the following year, 2 experts forecast that Medifast's EBITDA will decrease by 8.54%, to $127.60M. In 2030, professionals predict that Medifast's EBITDA will decrease by 9.42%, to $126.37M.
Medifast EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Medifast's EBIT has decreased by 6.65%, going from $135.40M to $126.40M. 2 analysts predict Medifast's EBIT will decrease by 14.52% in the next year, reaching $108.05M. By 2030, professionals predict that Medifast's EBIT will decrease by 17.61%, to $104.14M.
Medifast EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Medifast's EPS has seen a drop from $9.14 to $0.00 – a 100.00% decrease. Next year, analysts are expecting EPS to reach $7.68 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)